Page last updated: 2024-11-11

3-hexenylacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hexenylacetate: RN refers to (Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5352557
CHEBI ID180297
SCHEMBL ID316945
SCHEMBL ID113310
MeSH IDM0387108

Synonyms (49)

Synonym
3-hexen-1-ol, 1-acetate
einecs 216-965-8
LS-13476
3e-hexenyl acetate
1708-82-3
CHEBI:180297
[(e)-hex-3-enyl] acetate
3-hexen-1-ol, acetate, (e)-
(3e)-3-hexenyl acetate
3-hexenylacetate
hex-3-enyl acetate
LMFA07010179
AKOS006229485
AM806731
3-hexenyl acetate
3-hexen-1-ol, acetate, (3e)-
e556g2eozd ,
3-hexenyl acetate, (3e)-
trans-3-hexenyl acetate
3681-82-1
einecs 222-962-2
3-hexen-1-ol, 1-acetate, (3e)-
unii-e556g2eozd
ai3-33358
(e)-hex-3-enyl acetate
3-hexen-1-ol,1-acetate, (3e)-
SCHEMBL316945
SCHEMBL113310
(e)-3-hexen-1-ol acetate
fema no. 4413
(e)-3-hexenyl acetate
trans-3-hexenyl acetate [fhfi]
3-hexenyl acetate, trans-
trans-3-hexen-1-ol acetate
(e)-3-hexen-1-yl acetate
acetic acid trans-3-hexenyl ester
(e)-hex-3-en-1-yl acetate
(3e)-hexenyl acetate
NPFVOOAXDOBMCE-SNAWJCMRSA-N
(e)-3-hexenol acetate
(3e)-3-hexenyl acetate #
trans-3-hexen-1-ol, acetate
(e)-hex-3-enol acetate
acetate(e)-3-hexen-1-ol
1-acetate(3e)-3-hexen-1-ol
acetate(3e)-3-hexen-1-ol
hexenyl acetate (3e-)
Q27276882
DTXSID00880889
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carboxylic esterAn ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (33.33)29.6817
2010's26 (54.17)24.3611
2020's6 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.78 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (97.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]